company background image
20259063 logo

Coloplast BRSE:020259063 Stock Report

Last Price

CHF109.67

Market Cap

CHF24.5b

7D

0%

1Y

-4.6%

Updated

14 Dec, 2022

Data

Company Financials +

20259063 Stock Overview

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.

20259063 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance2/6
Financial Health3/6
Dividends3/6

Coloplast A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Coloplast
Historical stock prices
Current Share Pricekr.109.67
52 Week Highkr.143.26
52 Week Lowkr.102.98
Beta0.24
1 Month Change0%
3 Month Changen/a
1 Year Change-4.64%
3 Year Change-0.17%
5 Year Change41.23%
Change since IPO33.34%

Recent News & Updates

Recent updates

Shareholder Returns

20259063CH Medical EquipmentCH Market
7D0%0.5%0.8%
1Y-4.6%15.8%3.3%

Return vs Industry: 020259063 underperformed the Swiss Medical Equipment industry which returned 4.1% over the past year.

Return vs Market: 020259063 underperformed the Swiss Market which returned -0.9% over the past year.

Price Volatility

Is 20259063's price volatile compared to industry and market?
20259063 volatility
20259063 Average Weekly Movementn/a
Medical Equipment Industry Average Movement3.7%
Market Average Movement3.4%
10% most volatile stocks in CH Market7.7%
10% least volatile stocks in CH Market1.8%

Stable Share Price: 020259063 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 020259063's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
195414,572Kristian Villumsenhttps://www.coloplast.com

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.

Coloplast A/S Fundamentals Summary

How do Coloplast's earnings and revenue compare to its market cap?
20259063 fundamental statistics
Market capCHF24.53b
Earnings (TTM)CHF622.66m
Revenue (TTM)CHF2.99b

39.4x

P/E Ratio

8.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
20259063 income statement (TTM)
Revenuekr.22.58b
Cost of Revenuekr.7.05b
Gross Profitkr.15.53b
Other Expenseskr.10.82b
Earningskr.4.71b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 03, 2023

Earnings per share (EPS)22.17
Gross Margin68.78%
Net Profit Margin20.84%
Debt/Equity Ratio217.1%

How did 20259063 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

90%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.